Details of the Metabolic Reaction (MR)
| General Information of This Metabolic Reaction (MR) (ID: MR003754) | ||||||
|---|---|---|---|---|---|---|
| Formula | Reactant | LY-2484595 | Product | LY-2484595 Metabolite M5 | ||
| Reactant Info | Product Info | |||||
| Metabolic Type | Oxidation - Oxidationn | |||||
| Other MR(s) Related to The Reactant of This MR | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other MR(s) That Metabolize The Reactant of This MR | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| References | ||||||
|---|---|---|---|---|---|---|
| 1 | Evacetrapib: in?vitro and clinical disposition, metabolism, excretion, and assessment of drug interaction potential with strong CYP3A and CYP2C8 inhibitors | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.